These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 2152729

  • 1. [Cholestyramine in the treatment of hypercholesterolemia. Our experience in 11 cases].
    Maíz A, Arteaga A, Villanueva CL, Velasco N, Acosta AM.
    Rev Med Chil; 1990 Sep; 118(9):1009-13. PubMed ID: 2152729
    [Abstract] [Full Text] [Related]

  • 2. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia].
    Jover E, Aranda JL, Nogués X, del Palacio A, Rubiés-Prat J.
    Med Clin (Barc); 1996 May 25; 106(20):776-9. PubMed ID: 8801396
    [Abstract] [Full Text] [Related]

  • 3. Comparative study of a microporous cholestyramine analogue (filicol) and gemfibrozil for treatment of severe primary hypercholesterolemia. Short- and long-term results.
    Ros E, Zambón D, Bertomeu A, Cusó E, Sanllehy C, Casals E.
    Arch Intern Med; 1991 Feb 25; 151(2):301-5. PubMed ID: 1992957
    [Abstract] [Full Text] [Related]

  • 4. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
    Arch Intern Med; 1993 Jun 14; 153(11):1321-9. PubMed ID: 8507122
    [Abstract] [Full Text] [Related]

  • 5. Therapy of familial hypercholesterolemia in childhood: diet and cholestyramine resin for 24 to 36 months.
    Glueck CJ, Tsang RC, Fallat RW, Mellies M.
    Pediatrics; 1977 Mar 14; 59(3):433-41. PubMed ID: 840563
    [Abstract] [Full Text] [Related]

  • 6. Probucol and cholestyramine combination in the treatment of severe hypercholesterolemia.
    Sommariva D, Bonfiglioli D, Tirrito M, Pogliaghi I, Branchi A, Cabrini E.
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep 14; 24(9):505-10. PubMed ID: 3781686
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Effects of low-dose cholestyramine in long-term therapy of hypercholesterolemia].
    Cattin L, Da Col PG, Fonda M, Mazzone C, Pertot P.
    G Clin Med; 1990 Feb 14; 71(2):99-104. PubMed ID: 2347462
    [Abstract] [Full Text] [Related]

  • 11. Comparison of simvastatin and cholestyramine in the treatment of primary hypercholesterolaemia.
    O'Brien RC, Simons LA, Clifton P, Cooper ME, Jennings GL, Jerums G, Nestel PJ, Sullivan D.
    Med J Aust; 1990 May 07; 152(9):480-3. PubMed ID: 2199801
    [Abstract] [Full Text] [Related]

  • 12. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I.
    Stein E, Kreisberg R, Miller V, Mantell G, Washington L, Shapiro DR.
    Arch Intern Med; 1990 Feb 07; 150(2):341-5. PubMed ID: 2405804
    [Abstract] [Full Text] [Related]

  • 13. Etofibrate therapy and effect of added low-dose cholestyramine in patients with combined hyperlipidaemia.
    Krüger B.
    Int J Clin Pharmacol Res; 1994 Feb 07; 14(5-6):177-83. PubMed ID: 7672874
    [Abstract] [Full Text] [Related]

  • 14. Combined drug therapy for familial hypercholesterolemia.
    Packard CJ, Stewart JM, Morgan HG, Lorimer AR, Shepherd J.
    Artery; 1980 Feb 07; 7(4):281-9. PubMed ID: 7213018
    [Abstract] [Full Text] [Related]

  • 15. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia].
    Lechleitner M, Sailer S, Irsigler H, Klein W, Patsch JR.
    Wien Med Wochenschr; 1995 Feb 07; 145(21):577-83. PubMed ID: 8560901
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of low-dose cholesterol-lowering drug therapy in men with moderate hypercholesterolemia.
    Denke MA, Grundy SM.
    Arch Intern Med; 1995 Feb 27; 155(4):393-9. PubMed ID: 7848022
    [Abstract] [Full Text] [Related]

  • 17. DEAE-Dextran in the treatment of primary hypercholesterolemia and/or hypercholesterolemia combined with hypertriglyceridemia. A multicentric randomized study on the efficacy of DEAE-Dextran compared with Cholestyramine.
    Fedele F.
    Clin Ter; 2003 Feb 27; 154(4):231-6. PubMed ID: 14618939
    [Abstract] [Full Text] [Related]

  • 18. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW, Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group.
    Clin Ther; 2004 Sep 27; 26(9):1388-99. PubMed ID: 15531001
    [Abstract] [Full Text] [Related]

  • 19. Effects of lovastatin (20-80 mg daily) on lipoprotein fractions in patients with severe primary hypercholesterolemia.
    März W, Grützmacher P, Paul D, Siekmeier R, Schoeppe W, Gross W.
    Int J Clin Pharmacol Ther; 1994 Feb 27; 32(2):92-7. PubMed ID: 8004365
    [Abstract] [Full Text] [Related]

  • 20. [Lovastatin in primary hypercholesterolemia. A Norwegian multicenter study].
    Ose L.
    Tidsskr Nor Laegeforen; 1992 Nov 30; 112(29):3665-9. PubMed ID: 1471127
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.